2van Bmmel F, de Man RA, Wedemeyer H, et al. Long - term efficacy of tenofovir monotherapy for hepatitis B virus mono infected patients after failure of nueleoside/nucleotide analogues [J]. Hematology, 2010, 51 (1) : 73 -80.
3Jayakumar R, Joshi YK, Singh S. Laboratory evaluation of three regi- mens of treatment of ehronie hepatitis B : tenofovir, endeavor and combi- nation of lamivudine and adenoviral [J]. J Lab Physicians, 2012, 4 (1): 10-16.
4Lu JJ, Liu K, Ma Y J, et al. Efficacy and safety of telbivudine plus ad- enoviral dipivoxil combination therapy and endeavor immunotherapy for HBeAg - positive chronic hepatitis B patients with resistance to adenovi- raldipivoxil [J] .JViralHepat, 2013, 20 (1): 40-45.
5Hagiwara S, Kudo M, Osaki Y, et al. Impact of peg interferon alpha -2b and endeavor hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B [J]. J Med Virol, 2013, 85 (6):987-995.
6De Lima LB,Busin L. The nurse's perspective on humanized care in a post-anesthesic care unit[J].Revista Gaucha de Enfermagem,2008,(01):90-97.